HealthCare Middle East & Africa Magazine Newsletter - April 23, 2024

HealthCare Middle East & Africa Magazine Newsletter - April 23, 2024

AFRICAN & MIDDLE EAST NEWS HEADLINES  

Tanzania launches HPV vaccination campaign

TANZANIA—The Ministry of Health of the United Republic of Tanzania, in collaboration with Gavi, and other partners, has launched a national multi-age cohort (MAC) vaccination campaign against human papillomavirus (HPV), the primary cause of cervical cancer. . . Read More

"Tootsie Roll" technique gives second chance to patient with leaky valve

SOUTH AFRICA— Tygerberg Hospital in Cape Town has achieved another milestone after a team of doctors executed a pioneering treatment to fix a patient's leaking heart valve... Read More

Revna Biosciences earns twin ISO Certifications

GHANA – Revna Biosciences, a Ghanian biomedical company , has received twin ISO certifications: ISO 15189:2022 for clinical diagnostics and ISO 20387:2018 for biobanking to advance precision medicine in Ghana and West Africa. . .Read More

Dubai establishes new disaster and crisis management office

UAE—The Dubai Health Authority (DHA) has established a disaster and crisis management office to manage emergency situations and promote community health security effectively. . . Read More

Elegancia partners with Iraqi Ministry of Health to manage Al Hasan Al Mujtaba Teaching Hospital

IRAQ— The Iraqi Ministry of Health has reached a second agreement with Elegancia Healthcare, a subsidiary of Qatar-based Estithmar Holding, to run the 492-bed Al Hasan Al Mujtaba Teaching Hospital in Iraq's Karbala Governorate. . . Read More

Fakeeh Care Group to go public in Saudi Arabia’s active IPO market

SAUDI ARABIA—Fakeeh Care Group, the largest private hospital chain in Saudi Arabia, has announced plans to go public through an Initial Public Offering (IPO). . . Read More

WORLD NEWS HEADLINES  

UK announces US$9.3M boost to fight malaria globally

UK— The UK has announced a £7.4 million (US$9.26 million) financing project to expand global access to malaria medications and tests, aiming to reach more than 50 million people by 2027. . . Read More

Bristol Myers Squibb partners with Cellares to boost CAR-T manufacturing

USA—Bristol Myers Squibb, an American biopharmaceutical company, has forged a strategic relationship with Cellares, a pioneer in Integrated Development and Manufacturing Organizations (IDMOs), to establish a capacity reserve and supply agreement for CAR T cell treatments. . . Read More

Apollo HealthCo merges pharmacy unit with Keimed in US$297 M deal

INDIA—Advent International, a private equity firm, has announced plans to invest 24.75 billion rupees (US$297 million) in Apollo Hospitals' Apollo HealthCo section and integrate its online pharmacy business with pharmaceutical distributor Keimed. . . Read More

Vertex to acquire Alpine Immune Sciences  for  US$4.9B

USA—Vertex Pharmaceuticals has announced plans to buy Alpine Immune Sciences and its experimental kidney disease medicine, povetacicept, for $4.9 billion in cash. . . Read More


To view or add a comment, sign in

Insights from the community

Others also viewed

Explore topics